Literature DB >> 17943409

Epithelioid leiomyosarcoma with rhabdoid features.

Gülnur Yorulmaz1, Gülgün Erdogan, Hadice Elif Pestereli, Burhan Savas, Fatma Seyda Karaveli.   

Abstract

Leiomyosarcomas (LMS) are the most common type of uterine sarcoma. Most LMS have typical histologic features, and variants such as epithelioid LMS, myxoid LMS, LMS with osteoclast-like giant cells and LMS with rhabdoid features occur only rarely. Rhabdoid cells were first described in rhabdoid tumor, a distinctive renal neoplasm of infancy. Such tumors are composed of diffuse proliferation of rhabdoid cells that are round or polygonal in shape with eccentric nuclei, prominent nucleoli and glassy eosinophilic cytoplasm containing hyaline-like inclusion bodies. In the literature, extrarenal localizations of malign rhabdoid tumors have been described in a variety of primary sites such as the central nervous system, liver, skin and soft tissues. These characteristic rhabdoid cells have been reported in sarcomas and carcinomas of various types and in a few cases of uterine sarcomas. The presence of rhabdoid cells in tumors is considered to be a predictor of aggressive tumor behavior. Our case is that of a 56-year-old woman who was admitted to the state hospital with left inguinal mass. Microscopically the tumor was admixed of three different types of cell with spindle, epithelioid or rhabdoid features. Immunopositive cytoplasmic staining for myoglobulin and desmin was seen in rhabdoid cells, and cytokeratin immunopositivity was observed in epithelioid and some rhabdoid cells. Epithelioid cells and spindle cells were also SMA positive. The histopathologic and immunohistochemical findings support the diagnosis of epithelioid LMS with rhabdoid features. We report this very uncommon LMS variant; to the best of our knowledge there are only a few cases in the English literature.

Entities:  

Mesh:

Year:  2007        PMID: 17943409     DOI: 10.1007/s00508-007-0822-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  13 in total

1.  Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53.

Authors:  Xavier Leroy; Laurent Zini; David Buob; Charles Ballereau; Arnauld Villers; Sebastien Aubert
Journal:  Arch Pathol Lab Med       Date:  2007-01       Impact factor: 5.534

2.  Rhabdoid features in leiomyosarcoma of soft tissue: with special reference to aggressive behavior.

Authors:  Y Oshiro; H Shiratsuchi; Y Oda; S Toyoshima; M Tsuneyoshi
Journal:  Mod Pathol       Date:  2000-11       Impact factor: 7.842

Review 3.  Malignant mixed Müllerian tumor with rhabdoid features: a report of two cases and a review of the literature.

Authors:  D Y Baschinsky; T H Niemann; L A Eaton; W L Frankel
Journal:  Gynecol Oncol       Date:  1999-04       Impact factor: 5.482

4.  Aggressive uterine sarcoma with rhabdoid features: diagnosis by peritoneal fluid cytology and absence of INI1 gene mutation.

Authors:  J Knapik; A T Yachnis; D Ripley; J A Biegel; S Rathor; N S Hardt; A Talerman; E J Wilkinson
Journal:  Hum Pathol       Date:  2001-08       Impact factor: 3.466

5.  Urothelial carcinoma with rhabdoid features: report of 6 cases.

Authors:  Anil V Parwani; Mehsati Herawi; Keith Volmar; Shyh-Haw Tsay; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2006-02       Impact factor: 3.466

6.  The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells.

Authors:  Patricia Albanese; Marie-France Belin; Olivier Delattre
Journal:  Eur J Cancer       Date:  2006-09       Impact factor: 9.162

Review 7.  Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.

Authors:  Yoshinao Oda; Masazumi Tsuneyoshi
Journal:  Pathol Int       Date:  2006-06       Impact factor: 2.534

8.  hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.

Authors:  F Bourdeaut; P Fréneaux; B Thuille; A Lellouch-Tubiana; A Nicolas; J Couturier; G Pierron; C Sainte-Rose; C Bergeron; R Bouvier; X Rialland; V Laurence; J Michon; X Sastre-Garau; O Delattre
Journal:  J Pathol       Date:  2007-02       Impact factor: 7.996

9.  Leiomyosarcoma of the uterus with focal rhabdomyosarcomatous differentiation.

Authors:  Masayuki Shintaku; Kentarou Sekiyama
Journal:  Int J Gynecol Pathol       Date:  2004-04       Impact factor: 2.762

10.  Dumbbell-shaped leiomyosarcoma of the inferior vena cava with foci of rhabdoid changes and osteoclast-type giant cells.

Authors:  Takashi Nikaido; Yasuhiko Endo; Satoshi Nimura; Hiroshi Ishikura; Shinichiro Ushigome
Journal:  Pathol Int       Date:  2004-04       Impact factor: 2.534

View more
  5 in total

1.  Renal cell carcinoma with rhabdoid and sarcomatoid features presented as a metastatic thigh mass with an unusual immunohistochemical profile.

Authors:  Asmaa Gaber Abdou; Mona Kandil; Soliman Elshakhs; Marwa Serag El-Dien; Rania Abdallah
Journal:  Rare Tumors       Date:  2014-03-18

2.  Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics.

Authors:  Stephanie E W Punt; Janet F Eary; Janet O'Sullivan; Ernest U Conrad
Journal:  Nucl Med Commun       Date:  2009-07       Impact factor: 1.690

Review 3.  Sporadic haemangioblastoma of the kidney with rhabdoid features and focal CD10 expression: report of a case and literature review.

Authors:  Wei-hua Yin; Jian Li; John K C Chan
Journal:  Diagn Pathol       Date:  2012-04-12       Impact factor: 2.644

4.  Leiomyosarcoma with partial rhabdomyoblastic differentiation: first case report of primary cardiac origin.

Authors:  Yoichiro Okubo; Kazutoshi Shibuya; Atsushi Namiki; Kazuhisa Takamura; Noriaki Kameda; Tetsuo Nemoto; Aki Mitsuda; Megumi Wakayama; Minoru Shinozaki; Nobuyuki Hiruta; Kanako Kitahara; Takao Ishiwatari; Junichi Yamazaki
Journal:  BMC Cancer       Date:  2011-02-17       Impact factor: 4.430

5.  Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

Authors:  Jeong Yeol Park; Jeong Won Lee; Hyun Ju Lee; Jong Jin Lee; Seung Hwan Moon; Seo Young Kang; Gi Jeong Cheon; Hyun Hoon Chung
Journal:  J Gynecol Oncol       Date:  2017-02-02       Impact factor: 4.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.